Related references
Note: Only part of the references are listed.Mitochondrial Regulation of Diabetic Kidney Disease
Daniel L. Galvan et al.
FRONTIERS IN MEDICINE (2021)
Microvascular Complications of Type 2 Diabetes Mellitus
Charles Faselis et al.
CURRENT VASCULAR PHARMACOLOGY (2020)
Preventing and treating kidney disease in patients with type 2 diabetes
Pierre Delanaye et al.
EXPERT OPINION ON PHARMACOTHERAPY (2019)
RAAS inhibitors directly reduce diabetes-induced renal fibrosis via growth factor inhibition
Sandor Koszegi et al.
JOURNAL OF PHYSIOLOGY-LONDON (2019)
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
N. H. Cho et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2018)
NR4A1 Promotes Diabetic Nephropathy by Activating Mff-Mediated Mitochondrial Fission and Suppressing Parkin-Mediated Mitophagy
Junqin Sheng et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Phosphate Binder, Ferric Citrate, Attenuates Anemia, Renal Dysfunction, Oxidative Stress, Inflammation, and Fibrosis in 5/6 Nephrectomized CKD Rats
Wanghui Jing et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)
Dietary tetrahydrocurcumin reduces renal fibrosis and cardiac hypertrophy in 5/6 nephrectomized rats
Wei Ling Lau et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2018)
Circulating fibronectin contributes to mesangial expansion in a murine model of type 1 diabetes
Verena Klemis et al.
KIDNEY INTERNATIONAL (2017)
Comparison of the effects of levocetirizine and losartan on diabetic nephropathy and vascular dysfunction in streptozotocin-induced diabetic rats
Hanan S. Anbar et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Uninephrectomized High-Fat-Fed Nicotinamide-Streptozotocin-Induced Diabetic Rats: A Model for the Investigation of Diabetic Nephropathy in Type 2 Diabetes
Valentina K. Bayrasheva et al.
JOURNAL OF DIABETES RESEARCH (2016)
Transforming growth factor-β1 and diabetic nephropathy
Albert S. Chang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2016)
Proteinuria and its relation to cardiovascular disease
Gemma Currie et al.
INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE (2014)
Complementary and Alternative Medicine for Diabetes
Wen-Chin Yang et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)
Curcumin alleviates oxidative stress, inflammation, and renal fibrosis in remnant kidney through the Nrf2-keap1 pathway
Vivian Soetikno et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2013)
The protective effect of losartan in the nephropathy of the diabetic rat includes the control of monoamine oxidase type A activity
Maria Elena Manni et al.
PHARMACOLOGICAL RESEARCH (2012)
Rho kinase inhibition protects kidneys from diabetic nephropathy without reducing blood pressure
Radko Komers et al.
KIDNEY INTERNATIONAL (2011)
Effects of Spironolactone and Losartan on Diabetic Nephropathy in a Type 2 Diabetic Rat Model
Mi Young Lee et al.
DIABETES & METABOLISM JOURNAL (2011)
Combined treatment of tetrahydrocurcumin and chlorogenic acid exerts potential antihyperglycemic effect on streptozotocin-nicotinamide-induced diabetic rats
Krishnamoorthy Karthikesan et al.
GENERAL PHYSIOLOGY AND BIOPHYSICS (2010)
The RAAS in the pathogenesis and treatment of diabetic nephropathy
Piero Ruggenenti et al.
NATURE REVIEWS NEPHROLOGY (2010)
Reduction of Renal Superoxide Dismutase in Progressive Diabetic Nephropathy
Hiroki Fujita et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets
Bharat B. Aggarwal et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Bioavailability of curcumin: Problems and promises
Preetha Anand et al.
MOLECULAR PHARMACEUTICS (2007)
Antihyperlipidemic effect of curcumin and tetrahydrocurcumin in experimental type 2 diabetic rats
Leelavinothan Pari et al.
RENAL FAILURE (2007)
High-fat diet in low-dose-streptozotocin-treated heminephrectomized rats induces all features of human type-2 diabetic nephropathy: A new rat model of diabetic nephropathy
Sugano Mikio et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2006)
Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy
DJ Kennedy et al.
HYPERTENSION (2006)
Kidney expression of glutathione peroxidase-1 is not protective against streptozotocin-induced diabetic nephropathy
JB de Haan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)
Diminished loss of Proteoglycans and lack of albuminuria in protein kinase C-α-deficient diabetic mice
J Menné et al.
DIABETES (2004)
Cytoprotective effects of polyenoylphosphatidylcholine (PPC) on β-cells during diabetic induction by streptozotocin
SH Lee et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2003)
Curcumin and especially tetrahydrocurcumin ameliorate oxidative stress-induced renal injury in mice
K Okada et al.
JOURNAL OF NUTRITION (2001)